Array BioPharma, Inc. (NASDAQ:ARRY)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.
RSS Headlines
Fool UK
Recs
Could show serious growth of this decade.